Fc Receptors e-bog
1386,89 DKK
(inkl. moms 1733,61 DKK)
This volume provides a state-of-the-art update on Fc Receptors (FcRs). It is divided into five parts. Part I, Old and New FcRs, deals with the long-sought-after FcuR and the recently discovered FCRL family and TRIM21. Part II, FcR Signaling, presents a computational model of FcI RI signaling, novel calcium channels, and the lipid phosphatase SHIP1. Part III, FcR Biology, addresses major physiol...
E-bog
1386,89 DKK
Forlag
Springer
Udgivet
12 august 2014
Genrer
Medical research
Sprog
English
Format
pdf
Beskyttelse
LCP
ISBN
9783319079110
This volume provides a state-of-the-art update on Fc Receptors (FcRs). It is divided into five parts. Part I, Old and New FcRs, deals with the long-sought-after FcuR and the recently discovered FCRL family and TRIM21. Part II, FcR Signaling, presents a computational model of FcI RI signaling, novel calcium channels, and the lipid phosphatase SHIP1. Part III, FcR Biology, addresses major physiological functions of FcRs, their glycosylation, how they induce and regulate both adaptive immune responses and inflammation, especially in vivo, FcR humanized mice, and the multifaceted properties of FcRn. Part IV, FcRs and Disease, discusses FcR polymorphism, FcRs in rheumatoid arthritis and whether their FcRs make macaques good models for studying HIV infection. In Part V, FcRs and Therapeutic Antibodies, the roles of various FcRs, including FcyRIIB and FcaRI, in the immunotherapy of cancer and autoimmune diseases using monoclonal antibodies and IVIg are highlighted. All 18 chapters were written by respected experts in their fields, offering an invaluable reference source for scientists and clinicians interested in FcRs and how to better master antibodies for therapeutic purposes.